Menu ×

HEALTHCARE & PHARMACEUTICAL

Anatomic Pathology Market Analysis by Type (Services, Consumables, and Instruments); by Subdivision (Histopathology and Cytopathology); by Application (Disease Diagnosis and Drug Discovery & Development); and by End-User (Hospitals, Diagnostic Laboratories, and Research & Academic Laboratories) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More

IN THE NEWS

  • Epredia, – a subsidiary of PHC Holdings Corporation announced that its parent company has acquired anatomical pathology suppliers Laurypath and Microm Microtech France (MMFrance) to mark strategic expansion of Epredia’s presence in Europe.
  •  Indica Labs, Inc., – with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics(iCAIRD), announced an agreement to collaborate on the development of an AI-based digital pathology solution. The pathology will assist the detection of cancer within lymph nodes from colorectal surgery cases.

Global Anatomic Pathology Market Highlights Over 2023 - 2033

Base Year

2022

Forecast Year

2023-2033

CAGR

~9%

Base Year Market Size (2022)

~USD 24337 Million

Forecast Year Market Size (2033)

~USD 59424 Million

The global anatomic pathology market is estimated to garner a revenue of ~USD 59424 million by the end of 2033 by growing at a CAGR of ~9% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 24337 million in the year 2022. The growth of the market can primarily be attributed to the growing number of laboratory tests worldwide. For instance, every year over 7 billion clinical lab tests are performed in the United States.

Anatomic-Pathology-Market-Size

Get more information on this reportDownload Sample PDF

Anatomic (or anatomical) pathology being the branch of medicine studies the effects of particular disease on the structure of body organs and tissues. Anatomic pathology identifies abnormalities and help to diagnose disease and manage treatment. Most of the anatomic pathology is to help identify and manage various types of tumors or cancers, but it is also helps to evaluate other conditions. With the recent advancements digital pathology as well as Artificial Intelligence (AI), the demand for anatomic pathology is on the rise amongst the healthcare service providers, which in turn, is expected to create massive revenue generation opportunities for the key players operating in the global anatomic pathology market during the forecast period. For instance, as per a survey conducted on the integration of artificial intelligence into diagnostic pathology practice, out of 487 respondents, ~80 percent expected the integration in the upcoming 5 or 10 years, whereas ~70% predicted that AI tools could increase diagnostic efficiency in future.

Global Anatomic Pathology Market: Growth Drivers and Challenges

Growth Drivers

  • Growing Cancer Cases – Cancer cases are detected through anatomic pathology report. With the rising cases of cancer and need for biopsies to be performed, the market for anatomic pathology is expected to boost in the projected period. For instance, it was observed that approximately 19 million new cancer cases were registered worldwide in 2020.

  • Upsurge in the Number of Pathologists – According to reports, it was found that, in the United States there were ~21292 active pathologists in June 2019 compared ~12839 anatomical and clinical pathologists in 2017.

  • Rising Prevalence of Chron’s disease – According to reports, every year ~100 to 300 per 100,000 people suffer from Chron’s disease in North America and western Europe.
  • Growing Number of People Suffering from Kidney Disease –total number of people suffering from kidney disease is ~850 million worldwide in 2021.

Challenges

  • High Expenditure Associated in Developing Anatomic Pathology

  • Non-availability of Refurbished Anatomic Pathology Equipment

  • Challenges in Transformation of Pathology Trends

The global anatomic pathology market is segmented and analyzed for demand and supply by type into services, consumables, and instruments. Amongst these segments, the services segment – 48.12% held the largest share in 2022, backed by the growing number of breast cancers along with the surge in the number of biopsies done worldwide. For instance, over 17720 biopsies were recommended and performed, in between January 2019 to September 2020 in the United States.

Major Macro-Economic Indicators Impacting the Market Growth

Global-Healthcare-Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Anatomic Pathology Market Regional Synopsis

Regionally, the global anatomic pathology market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America held the largest market share of 39.21% in 2022, backed by the presence of a strong healthcare network in the region, growing number of hospitals and diagnostic centers, as well as the rising demand for advanced anatomic pathology amongst the healthcare service providers owing to the rising number of surgeries in the region. For instance, it was observed that, ~15 million Europeans have surgery every year. Some of the most common surgeries performed are appendectomy, breast biopsy, carotid endarterectomy, cholecystectomy, coronary artery bypass and others.

Anatomic-Pathology-Market

The global anatomic pathology market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global anatomic pathology market includes the following segments:

By Type

  • Services – 48.12%
  • Consumables – 40.70%
  • Instruments – 11.18%

By Subdivision

  • Histopathology
  • Cytopathology

By Product Type

  • Recombinant Non-Glycosylated Proteins - 63%
  • Recombinant Glycosylated Proteins - 32%
  • Recombinant Peptides - 5%

By Application

  • Disease Diagnosis
  • Drug Discovery & Development

By End-User

  • Hospitals
  • Diagnostic Laboratories,
  • Research & Academic Laboratories

Top Featured Companies Dominating the Global Anatomic Pathology Market

  • PHC Holdings Corporation
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Indica Labs, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Sakura Finetek USA, Inc.
  • Cardinal Health, Inc.
  • BioGenex
  • NeoGenomics Laboratories, Inc.
  • Agilent Technologies, Inc.

 

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved